Short and long-term outcomes of lung transplantation from brain death vs. circulatory death donors: A meta-analysis of comparative studies

To investigate through a meta-analysis of comparative studies the impact of donor type (brain death DBD vs circulatory death DCD) on the short- and long-term outcomes of lung transplantation(LTx). Literature search (terms “lung transplantation” AND “donation after circulatory death”) was performed u...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of heart and lung transplantation 2025-01
Hauptverfasser: Spadaccio, Cristiano, Salsano, Antonio, Altarabsheh, Salah, Castro-Varela, Alejandra, Gallego Navarro, Carlos, Juarez Casso, Fernando, Abdelrehim, Ahmed, Andi, Kartik, Ribeiro, Rafaela V.P., Choi, Kukbin, Knop, Gustavo, Kennedy, Cassie C., Pennington, Kelly M., Spencer, Philip J., Daly, Richard, Villavicencio, Mauricio, Cypel, Marcelo, Saddoughi, Sahar A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To investigate through a meta-analysis of comparative studies the impact of donor type (brain death DBD vs circulatory death DCD) on the short- and long-term outcomes of lung transplantation(LTx). Literature search (terms “lung transplantation” AND “donation after circulatory death”) was performed up to July 2022 and studies comparing outcomes of LTx from DCD versus DBD were selected. Primary endpoints were early and long-term mortality. Secondary outcomes included primary graft dysfunction (PGD),acute rejection and postoperative complications. The long-term survival was analyzed by retrieving data from each available Kaplan-Meier and restricted mean survival time difference between DBD and DCD for long-term survival was estimated. 21 studies were included comprising 60105 patients (DBD=58548 DCD=1557). Recipient and donor baseline characteristics were similar between the two groups. No significant publication bias was observed. The estimated pooled odds ratio of early mortality favored DBD (OR=0.75,CI=0.56–1.00, I2=0%). No statistically significant difference was observed in the risk of acute rejection (OR=1.33, CI=0.82–2.17), and PGD grade 2–3 (OR=0.88, CI=0.69–1.13). One- and 5-year survival were 82.1% and 51.2%, and 86.2% and 62.7% for DBD and DCD groups, respectively (Log-rank,p
ISSN:1053-2498
1557-3117
1557-3117
DOI:10.1016/j.healun.2024.12.010